Ad
MACK - Merrimack Pharmaceuticals Stock Trading
Merrimack Pharmaceuticals Inc. Company Name:
MACK Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its second quarter 2022 financial results for the period ended June 30, 2022. “We are pleased to report continued reductions in operating expenses as we...
-
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced that Ipsen, SA (“Ipsen”) has issued a press release today reporting its primary analysis of the results of its Phase 3 trial of Onivyde® (irinotecan l...
-
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2022 financial results for the period ended March 31, 2022. “During the first quarter of 2022 we continued to see reductions in our op...
Ad
Important Investor News Alert (OTCMKTS: GTCH)
-
This second 3D, MP microchip Application Seeks to Further Strengthen GBT’s Multi-Dimensional Integrated Circuits Design and Manufacturing Concept SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT” or the ...